These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16327022)
1. Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I. Blatter Garin MC; Moren X; James RW J Lipid Res; 2006 Mar; 47(3):515-20. PubMed ID: 16327022 [TBL] [Abstract][Full Text] [Related]
2. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease. Göçmen AY; Gümüşlü S; Semiz E Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047 [TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130 [TBL] [Abstract][Full Text] [Related]
4. The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity. Oniki K; Ohura K; Endo M; Akatwijuka D; Matsumoto E; Nakamura T; Ogata Y; Yoshida M; Harada-Shiba M; Saruwatari J; Ogura M; Imai T J Atheroscler Thromb; 2024 Sep; 31(9):1263-1276. PubMed ID: 38508740 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes. Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583 [TBL] [Abstract][Full Text] [Related]
6. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus. Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115 [TBL] [Abstract][Full Text] [Related]
7. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294 [TBL] [Abstract][Full Text] [Related]
8. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665 [TBL] [Abstract][Full Text] [Related]
9. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients. Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255 [TBL] [Abstract][Full Text] [Related]
10. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Gaidukov L; Tawfik DS Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586 [TBL] [Abstract][Full Text] [Related]
11. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance. Viktorinova A; Svitekova K; Stecova A; Krizko M Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia. Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339 [TBL] [Abstract][Full Text] [Related]
13. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. van Himbergen TM; Roest M; de Graaf J; Jansen EH; Hattori H; Kastelein JJ; Voorbij HA; Stalenhoef AF; van Tits LJ J Lipid Res; 2005 Mar; 46(3):445-51. PubMed ID: 15576850 [TBL] [Abstract][Full Text] [Related]
14. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia. Liu ML; James RW; Ylitalo K; Taskinen MR Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240 [TBL] [Abstract][Full Text] [Related]
15. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians. Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768 [TBL] [Abstract][Full Text] [Related]
16. Paraoxonase 1 status in the Thai population. Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216 [TBL] [Abstract][Full Text] [Related]
17. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388 [TBL] [Abstract][Full Text] [Related]
18. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity. Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326 [TBL] [Abstract][Full Text] [Related]
19. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558 [TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 activities and genetic variation in childhood obesity. Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]